NYXOAH S.A. revenue breakdown overview

NYXOAH S.A. revenue for the last year amounted to 4.35 M EUR, the most of which — 4.35 M EUR — came from its highest performing source at the moment, Hypoglossal Neurostimulations Therapy, the year earlier bringing 3.08 M EUR. The greatest contribution to the revenue figure was made by Germany — last year it brought NYXOAH S.A. 3.82 M EUR.